Research on hemophilia treatment is ongoing, with studies examining the efficacy and safety of various therapies, including gene therapy and new medications. Some treatments, such as concizumab and efanesoctocog alfa, have shown promising results in managing hemophilia A and B. The outcomes of these studies may potentially lead to advancements in hemophilia treatment, although the specifics of these developments are still emerging.